Showing posts with label Anticancer. Show all posts
Showing posts with label Anticancer. Show all posts
Monday, April 13, 2020

New drug limits cancer spreading

›
A research team that recently invented a drug to stop blood vessels from forming a treatment-resistant barrier around some cancers h...
Monday, April 20, 2015

Designed Molecules Trap Cancer Cells in Deadly Cages

›
Chemists have designed a carbohydrate-based molecule that can surround and strangle bone cancer cells by self-assembling into a tangle...
Tuesday, December 24, 2013

Bitter melon extract may have potential to fight head, neck cancer

›
Extract taken from an Asian vegetable may have therapeutic qualities to treat head and neck cancer, a Saint Louis University researcher ...
Tuesday, May 7, 2013

Research on soy-based treatment for colorectal cancer presented at AACR annual meeting

›
In continuation of my update on  genistein Genistein is one of several known isoflavones.Genistein was first isolated in 1899 from ...
Wednesday, May 1, 2013

Androgen receptors found to be a potential target in breast cancer

›
In continuation of my update on Enzalutamide We know that, The androgen receptor (AR), also known as NR3C4 (nuclear receptor subfa...
Wednesday, December 19, 2012

Hard-to-treat Myc-driven cancers may be susceptible to drug already used in clinic

›
In continuation of my update on  Everolimus Hard-to-treat Myc-driven cancers may be susceptible to drug already used in clinic ...
Tuesday, October 23, 2012

Astex Begins Phase 2 Cancer Trial | News | Drug Discovery and Development Magazine

›
Astex Begins Phase 2 Cancer Trial of  SGI-110 | News | Drug Discovery and Development Magazine
Wednesday, September 19, 2012

Cylene's Pol I inhibitor, CX-5461 activates p53 and selectively destroys cancer cells

›
Cylene Pharmaceuticals  announced that research collaborators at the Peter MacCallum Cancer Centre (Peter Mac) in Melbourne, Australia ha...
Wednesday, February 29, 2012

Skin cancer drug, vemurafenib may prolong survival in advanced cases: Study

›
In continuation of my update on  vemurafenib ... According to an international study a new treatment for advanced  skin cancer  almo...
Thursday, November 24, 2011

Coffee may protect against womb cancer: Study

›
 In continuation of my update on the benefits of coffee A new study shows that regular intake of coffee may significantly lower risk for...
Saturday, October 22, 2011

New dual drug combinations in development for various cancers

›
New dual drug combinations in development for various cancers : A rarely used—and as yet largely unproven—approach to drug development has ...
Thursday, September 22, 2011

Preclinical studies shows EmPAC more effective than Taxol

›
Cornerstone Pharmaceuticals, Inc. has announced the publication of data from preclinical studies on EmPAC™ (nanoparticle reformulation of p...
Wednesday, June 8, 2011

Positive results from Plexxikon's vemurafenib Phase 2 and 3 trial against metastatic melanoma

›
We know that, PLX-4032(RG7204, Vemurafenib) is a highly selective inhibitor of BRAF kinase activity, with an IC50 of 44 nmol/L against V600...
Tuesday, May 24, 2011

Coffee reduces prostate cancer risk

›
Coffee reduces prostate cancer risk
Saturday, May 14, 2011

Clinical study: Celecoxib drug may treat breast cancer

›
In continuation of m update on Celecoxib Clinical study: Celecoxib drug may treat breast cancer
Saturday, April 9, 2011

AstraZeneca receives FDA approval for vandetanib to treat medullary thyroid cancer

›
In continuation of my update on Vandetanib ,,,,, AstraZeneca receives FDA approval for vandetanib to treat medullary thyroid cancer
Saturday, March 12, 2011

Experimental drug effectively shuts off MCL1 gene and induces apoptosis

›
Structure -B (UNBS1450) Experimental drug effectively shuts off MCL1 gene and induces apoptosis
Saturday, February 12, 2011

Teaming broccoli with sprouts may make vegetable's anti-cancer effect twice as powerful

›
Teaming broccoli with sprouts may make vegetable's anti-cancer effect twice as powerful
Monday, January 31, 2011

Taxol reduces cell regeneration obstacles after spinal cord injury...

›
Scientists of the Max Planck Institute of Neurobiology in Martinsried and their colleagues from the Kennedy Krieger Institute and Uni...
Friday, January 28, 2011

Discovery of a Biochemical Basis for Broccoli's Cancer-Fighting Ability

›
In continuation of my update on broccoli and its anticancer activity ..... Fung-Lung Chung and colleagues showed in previous exper...